% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • SteveHyde SteveHyde Jan 24, 1998 8:59 AM Flag

    Pipeline is there -- not to worry

    Analysts seem to think that the droloxifene news will not have serious negative consequences, and that the pipeline is still strong.
    From Yahoo news --

    ``The droloxifene news is a disappointment and creates a question about the drug's potential for the
    other two indications Pfizer is still pursuing,'' said A.G. Edwards drug analyst Kenneth Nover.

    Nevertheless, Nover said it was easily offset by Pfizer's rich pipeline of other drugs, including Viagra
    (sildenafil) for erectile dysfunction, dofetilide for heart arrhythmia and Zeldox (ziprasidone) for

    Hambrecht & Quist analyst Alex Zisson said droloxifene might have achieved annual sales of $100
    million for treating breast cancer. By contrast, he said Viagra could eventually become a
    multibillion-dollar drug and dofetilide could achieve annual sales of $200 million to $500 million.

33.99+0.16(+0.47%)Sep 28 4:00 PMEDT